2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
1
Status
Completed
19
Unknown
3
Terminated
3
Recruiting
3
Active not recruiting
2
Withdrawn
1
Not yet recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Breast
2
Genitourinary
1
Conditions
Breast Neoplasms
2
Prostatic Neoplasms
1
Neuritis
1
Interventions
Cyclophosphamide
390
Carboplatin
344
Gemcitabine
332
pembrolizumab
329
Cisplatin
328
Paclitaxel
297
Radiotherapy
296
Docetaxel
286
Bevacizumab
253
Rituximab
234
Capecitabine
223
Nivolumab
220
Dexamethasone
206
Fluorouracil
190
fludarabine
177
Oxaliplatin
177
Pemetrexed
153
Doxorubicin
153
Irinotecan
148
Leucovorin
144
Etoposide
144
Cytarabine
133
Cetuximab
129
Bortezomib
129
fludarabine phosphate
128
Lenalidomide
126
Erlotinib Hydrochloride
120
Filgrastim
119
Temozolomide
113
Radiosurgery
113
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Terminated
×
Massage
×
Clear all
NCT04202640
2026-03-18
PRESSODOU
Centre Oscar Lambret
Phase NA
Terminated
80 enrolled
NCT05067777
2025-12-15
mPROSTATE
University of Utah
Phase 2
Terminated
28 enrolled
NCT03557554
2019-08-26
PIPN
Indiana University
Phase NA
Terminated
5 enrolled